Antibodies · 2024 · 10 citations · 73 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoantibodiesAutoantibody-mediated DiseaseAutoantigensAutoimmune Disease PathogenesisAutoimmune DiseasesIdiopathic Inflammatory MyopathiesImmune-mediated MyopathiesImmune-mediated Necrotizing MyopathyKnockout Mouse ModelsMyofiber NecrosisNecrotizing Autoimmune MyopathySerum Creatine Kinase AssessmentSkeletal MyopathyTransgenic Mouse Models
Immune-mediated necrotizing myopathy (IMNM) is a rare and severe disease that corresponds to a specific entity of idiopathic inflammatory myopathy. Patients with IMNM suffer from proximal muscle weakness, and present high levels of creatine kinase and necrotic myofibers. Anti-Signal Recognition Particle (SRP) and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies (HMGCR) have recently been identified in two thirds of patients with IMNM and are used as a hallmark of the disease. In this review, we provide a detailed description of these antibodies and the tests used to detect them in the serum of patients. Based on in vitro studies and mouse models of IMNM, we discuss the role of autoantibodies in the pathogenesis of the disease. Finally, in the light of the latest knowledge, we conclude with a review of recent therapeutic approaches in IMNM.
73
Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai et al. · Annals of the Rheumatic Diseases · 2017 · 1.5K citations · Full text
Medicine, Dermatology, Pediatrics +13
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Andréas Mackensen, Fabian Müller, Dimitrios Mougiakakos et al. · Nature Medicine · 2022 · 999 citations
Jessica E. Hoogendijk, Anthony A. Amato, Bryan Lecky et al. · Neuromuscular Disorders · 2004 · 937 citations
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Sean J. Pittock, Achim Berthele, Kazuo Fujihara et al. · New England Journal of Medicine · 2019 · 846 citations · Full text